These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 11168514

  • 1. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
    Sezer O, Jakob C, Eucker J, Niemöller K, Gatz F, Wernecke K, Possinger K.
    Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514
    [Abstract] [Full Text] [Related]

  • 2. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H, Wierzbowska A, Robak T.
    Eur Cytokine Netw; 2003 Feb; 14(1):40-51. PubMed ID: 12799213
    [Abstract] [Full Text] [Related]

  • 3. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [Abstract] [Full Text] [Related]

  • 4. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Jan; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 6. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.
    Iwasaki T, Hamano T, Ogata A, Hashimoto N, Kitano M, Kakishita E.
    Br J Haematol; 2002 Mar; 116(4):796-802. PubMed ID: 11886383
    [Abstract] [Full Text] [Related]

  • 8. Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.
    Dmoszyńska A, Bojarska-Junak A, Domański D, Roliński J, Hus M, Soroka-Wojtaszko M.
    Leuk Lymphoma; 2002 Feb; 43(2):401-6. PubMed ID: 11999576
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
    Wallner G, Ciechański A, Dabrowski A, Kozłowski M, Roliński J, Laudański J, Cwik G.
    Folia Histochem Cytobiol; 2001 Feb; 39 Suppl 2():122-3. PubMed ID: 11820569
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
    Dirix LY, Vermeulen PB, Pawinski A, Prové A, Benoy I, De Pooter C, Martin M, Van Oosterom AT.
    Br J Cancer; 1997 Feb; 76(2):238-43. PubMed ID: 9231925
    [Abstract] [Full Text] [Related]

  • 11. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
    Ugurel S, Rappl G, Tilgen W, Reinhold U.
    J Clin Oncol; 2001 Jan 15; 19(2):577-83. PubMed ID: 11208853
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
    Heeschen C, Dimmeler S, Hamm CW, Boersma E, Zeiher AM, Simoons ML, CAPTURE (c7E3 Anti-Platelet Therapy in Unstable REfractory angina) Investigators.
    Circulation; 2003 Feb 04; 107(4):524-30. PubMed ID: 12566361
    [Abstract] [Full Text] [Related]

  • 13. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA, Tsirakis G, Kanellou P, Kaparou M, Stratinaki M, Xekalou A, Alegakis A, Boula A, Stathopoulos EN, Alexandrakis MG.
    Cytokine; 2011 Dec 04; 56(3):616-20. PubMed ID: 21940178
    [Abstract] [Full Text] [Related]

  • 14. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
    Sasaki H, Yukiue H, Kobayashi Y, Nakashima Y, Moriyama S, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.
    Surg Today; 2001 Dec 04; 31(11):1038-40. PubMed ID: 11766079
    [Abstract] [Full Text] [Related]

  • 15. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
    Clin Cancer Res; 2001 Mar 04; 7(3):538-43. PubMed ID: 11297245
    [Abstract] [Full Text] [Related]

  • 16. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY.
    Br J Cancer; 1999 May 04; 80(5-6):892-7. PubMed ID: 10360671
    [Abstract] [Full Text] [Related]

  • 17. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
    Schmidt NO, Westphal M, Hagel C, Ergün S, Stavrou D, Rosen EM, Lamszus K.
    Int J Cancer; 1999 Feb 19; 84(1):10-8. PubMed ID: 9988225
    [Abstract] [Full Text] [Related]

  • 18. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Lupus; 2002 Feb 19; 11(6):348-55. PubMed ID: 12139372
    [Abstract] [Full Text] [Related]

  • 19. Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia.
    Bairey O, Zimra Y, Shaklai M, Rabizadeh E.
    Br J Haematol; 2001 May 19; 113(2):400-6. PubMed ID: 11380405
    [Abstract] [Full Text] [Related]

  • 20. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
    Stompór T, Zdzienicka A, Motyka M, Dembińska-Kieć A, Davies SJ, Sulowicz W.
    Perit Dial Int; 2002 May 19; 22(6):670-6. PubMed ID: 12556068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.